
 [
{
"symbol" : "506128",
"exchange" : "BOM",
"id": "1139837",
"t" : "506128",
"e" : "BOM",
"name" : "Parnax Lab Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=PALA.BO",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:506128"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:506128"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:506128"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q1 (Mar \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "-3.40%",
"annual" : "3.79%",
"ttm" : "3.79%"
},
{
"title" : "Operating margin",
"recent_quarter" : "5.17%",
"annual" : "9.17%",
"ttm" : "9.17%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "13.12%",
"ttm" : "13.12%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "4.28%",
"ttm" : "4.28%"
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "12.20%",
"ttm" : "12.20%"
}
]
, "c" : "-0.60",
"l" : "56.00",
"cp" : "-1.06",
"ccol" : "chr",
"op" : "55.75",
"hi" : "57.00",
"lo" : "54.05",
"vo" : "2,701.00",
"avvo" : "",
"hi52" : "78.00",
"lo52" : "41.20",
"mc" : "483.53M",
"pe" : "13.27",
"fwpe" : "",
"beta" : "",
"eps" : "4.22",
"dy" : "",
"ldiv" : "",
"shares" : "8.50M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "1139837",
"name" : "Parnax Lab Ltd",
"t" : "506128",
"e" : "BOM",
"l" : "56.00",
"c" : "-0.60",
"mc" : "483.53M",
"cp" : "-1.06",
"ccol" : "chr"
}
,
{
"id" : "14699244",
"name" : "Veerhealth Care Ltd",
"t" : "511523",
"e" : "BOM",
"l" : "15.00",
"c" : "-0.70",
"mc" : "104.01M",
"cp" : "-4.46",
"ccol" : "chr"
}
,
{
"id" : "14985096",
"name" : "Coral Laboratories Ltd",
"t" : "524506",
"e" : "BOM",
"l" : "591.00",
"c" : "+0.60",
"mc" : "2.11B",
"cp" : "0.10",
"ccol" : "chg"
}
,
{
"id" : "663200192416002",
"name" : "Bafna Pharmaceuticals Limited",
"t" : "BAFNAPHARM",
"e" : "NSE",
"l" : "27.80",
"c" : "+0.25",
"mc" : "521.49M",
"cp" : "0.91",
"ccol" : "chg"
}
,
{
"id" : "201905350059104",
"name" : "Mercury Laboratories Ltd",
"t" : "538964",
"e" : "BOM",
"l" : "420.25",
"c" : "-5.00",
"mc" : "504.30M",
"cp" : "-1.18",
"ccol" : "chr"
}
,
{
"id" : "3289388",
"name" : "Medicamen Biotech Ltd",
"t" : "531146",
"e" : "BOM",
"l" : "691.95",
"c" : "+23.75",
"mc" : "7.86B",
"cp" : "3.55",
"ccol" : "chg"
}
,
{
"id" : "11018234",
"name" : "Syncom Formulations India Ltd",
"t" : "524470",
"e" : "BOM",
"l" : "1.53",
"c" : "-0.04",
"mc" : "1.19B",
"cp" : "-2.55",
"ccol" : "chr"
}
,
{
"id" : "321546676140049",
"name" : "Ganga Pharmaceuticals Ltd",
"t" : "539680",
"e" : "BOM",
"l" : "7.00",
"c" : "0.00",
"mc" : "",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "478315",
"name" : "Wintac Ltd",
"t" : "524758",
"e" : "BOM",
"l" : "236.50",
"c" : "-3.50",
"mc" : "2.37B",
"cp" : "-1.46",
"ccol" : "chr"
}
,
{
"id" : "7222829",
"name" : "Makers Laboratories Ltd",
"t" : "506919",
"e" : "BOM",
"l" : "81.35",
"c" : "+1.15",
"mc" : "406.07M",
"cp" : "1.43",
"ccol" : "chg"
}
,
{
"id" : "432750497476156",
"name" : "Alkem Laboratories Ltd",
"t" : "ALKEM",
"e" : "NSE",
"l" : "2,211.50",
"c" : "+30.20",
"mc" : "264.38B",
"cp" : "1.38",
"ccol" : "chg"
}
]
, "summary" : [{
"address": "GALA NO 114 BLDG NO 8 JOGANI INDUSTRIAL COMPLEX, CHUNABHATTI, MUMBAI, 400022, India",
"phone": "+91-22-30015666",
"fax": "+91-22-24057708",
"overview" : "Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. It is involved in developing oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations and special formulations. It offers liquid, cosmetics, herbal and nutraceuticals products. Its products include FEBRINAX PLUS DS, NAX-P SYRUP, ALERZINE SYRUP, PRED KID SYRUP, NAXIDEX Syrup, COL COL 125 SUSPENSION, BRUPAED SUSPENSION, BRONAX EXPECTORANT, BRONCHORLY SYRUP, BRONCHORYL PLUS SYRUP, ALBEROL 400 SUSPENSION, SONATRAX SYRUP, DASLIN NF SYRUP, ANTI DRUF LOTION, GASKNOT GEL, NAXPAR GRIPE WATER, DIGENAX, NAXAL, CYPRO-APETTI, PERIACT SYRUP, FYNALE SUSPENSION, METHERINE SUSPENSION, SONAQUINE SUSPENSION, NAXODEX COUGH SYRUP, PERIACTIN, NAXOMINIC QR DROPS, NAXOMINIC P SYRUP, NAXOMINIC QR SYRUP, PNEUMOKOF EXPECTORANT, NAXICO SYRUP and GRT SYRUP."
} ]
, "management" : [
{
"name" : "Prakash M. Shah",
"title" : "Chairman of the Board, Chief Executive Officer"
}
,
{
"name" : "Baiju M. Shah",
"title" : "Chief Financial Officer, Managing Director, Executive Director"
}
,
{
"name" : "Ami M. Shah",
"title" : "Women Non-Executive Director"
}
,
{
"name" : "Tirunillai V. Anatharaman",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Vindyak B. Desai",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Manharbhai N. Jhavari",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
